Loading...
Effect of Medicare Dialysis Payment Reform on Use of Erythropoiesis Stimulating Agents
OBJECTIVE: In 2011, the Centers for Medicare and Medicaid Services (CMS) replaced fee-for-service reimbursement for erythropoiesis stimulating agents (ESAs) with a fixed-sum bundled payment for all dialysis-related care and pay-for-performance incentives to discourage maintaining patients' hema...
Saved in:
| Published in: | Health Serv Res |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BlackWell Publishing Ltd
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4450930/ https://ncbi.nlm.nih.gov/pubmed/25355431 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1475-6773.12252 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|